search
Back to results

Effects of Different Types of Exercise in Type 2 Diabetes (RAED2)

Primary Purpose

Type 2 Diabetes

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Aerobic Training
Resistance Training
Sponsored by
Universita di Verona
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes focused on measuring aerobic training, resistance training, type 2 diabetes, therapy

Eligibility Criteria

40 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • BMI between 24-36 kg/m2;
  • HbA1c between 6.5-9.0%;
  • diabetes diagnosis must have been made at least 1 yr previously;
  • admitted diabetes treatments will be diet and oral hypoglycemic agents;
  • baseline physical activity, estimated by the IPAQ questionnaire, lower than 1000 MET min per week;
  • baseline body weight stable (changes lower than 2 kg in the last 2 months).

Exclusion Criteria:

  • moderate-severe somatic or autonomic neuropathy;
  • coronary heart disease;
  • peripheral or cerebral vascular disease;
  • preproliferative or proliferative retinopathy or chronic renal failure (serum creatinine >1.4 mg/dl in females; >1.5 mg/dl in males);
  • therapy with beta-blocker drugs;
  • smokers;
  • acute clinically significant intercurrent diseases;
  • inability to perform the scheduled physical activity programs.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Aerobic Exercise

    Resistance Exercise

    Arm Description

    The aerobic training group will use cardiovascular training devices.

    The resistance training group will perform exercises on weight machines and free weights.

    Outcomes

    Primary Outcome Measures

    Change in haemoglobin A1c (HbA1c) levels
    The measurement of HbA1c is carried out with a DCCT (Diabetes Control and Complications Trial)-aligned method.

    Secondary Outcome Measures

    Change in body weight
    Change in body composition
    Assessment by DEXA (Dual energy X-ray absorptiometry)
    Change in fasting plasma glucose levels
    Change in total cholesterol levels
    Change in HDL-cholesterol levels
    Change in LDL-cholesterol levels
    Change in triglycerides levels
    Change in blood pressure
    Change in insulin sensitivity
    Measured by euglycemic hyperinsulinemic clamp
    Change in energy expenditure
    Measured by indirect calorimetry
    Change in antidiabetic medications
    Class and dosage of blood-glucose lowering drugs are recorded before and at the end of the protocol.
    Compliance
    Attendance at the scheduled sessions is recorded for each patient.
    Change in beta-cell function
    Measured by OGTT (Oral Glucose Tolerance Test)
    Change in energy expenditure through voluntary physical activity
    Energy expenditure is estimated through metabolic Holter (Sense Wear Armband) and IPAQ (International physical activity questionnaire).
    Change in peak oxygen uptake
    Measured during an incremental exercise test
    Change in tissue oxygen extraction
    Measured by NIRS (Near-infrared spectroscopy) during an incremental test exercise
    Change in liver and muscle fat content
    Measured by Magnetic Resonance Imaging
    Change in blood glucose during and after exercise
    Measured by continuous glucose monitoring system
    Muscle strength
    Measured by 1RM (one-repetition maximum) test
    Change in 6 minutes walk distance
    This test measures the number of meters that can be walked in 6 minutes over a 30 m course. It is a simple field test to assess aerobic functional capacity.
    Change in flexibility
    Measured by "sit and reach" test and "back scratch" test
    Changes in expression in the muscle of some genes involved in ATP production, mitochondrial biogenesis and substrate utilization
    mRNA analysis with multiplex tandem real-time PCR of fine needle aspirates obtained from the vastus lateralis muscle

    Full Information

    First Posted
    August 16, 2010
    Last Updated
    August 24, 2011
    Sponsor
    Universita di Verona
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01182948
    Brief Title
    Effects of Different Types of Exercise in Type 2 Diabetes
    Acronym
    RAED2
    Official Title
    Comparison of Aerobic and Resistance Training Effects on Glycemic Control in Type 2 Diabetes
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2011
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2009 (undefined)
    Primary Completion Date
    December 2010 (Actual)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Universita di Verona

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purposes of this study are: a) to compare the effects of supervised programs of aerobic training or resistance training on the metabolic control of type 2 diabetes; b) to investigate some potential pathophysiologic and molecular mechanisms underlying these effects; c) to assess whether some changes may persist over time after termination of the supervised programs.
    Detailed Description
    Meta-analyses of studies which evaluated the effects of interventions based upon structured exercise programs in patients with type 2 diabetes show that regular physical activity may improve glycosylated haemoglobin (HbA1c) by 0.6-0.7%. Most studies assessed the effects of aerobic exercise. However, recent data suggest that resistance training may result in similar effects. It seems likely that these beneficial results are obtained through different molecular mechanisms by aerobic training and resistance training. Consequently, these exercise modalities could be synergistic in improving the metabolic abnormalities in these subjects. On the other hand, comparison data are very limited. Aims of the protocol are to compare the effects of aerobic training or resistance training on the metabolic control of type 2 diabetes and to investigate some potential pathophysiologic and molecular mechanisms underlying these effects. The study will be carried out in 40 sedentary type 2 diabetic patients without diabetic complications, aged 40-70 yr, with body mass index (BMI) between 24-36 kg/m2 and HbA1c between 6.5-9.0%. Admitted diabetes treatments will be diet and oral hypoglycemic agents. Subjects will be assigned, by a randomization schedule weighted by baseline BMI and fitness, to 2 groups of supervised exercise: aerobic training or resistance training. Training programs will have a similar volume and will be scheduled in three 60 min sessions per week for 4 months. During the study subjects will be instructed to follow an isocaloric diet. Before and at the end of the exercise training the following will be assessed: HbA1c (primary outcome), plasma glucose, lipid profile, blood pressure, insulin sensitivity (glucose clamp), body composition (Dual energy X-ray absorptiometry, DEXA), liver and muscle fat content (magnetic resonance imaging), expression in the muscle of some genes involved in ATP production, mitochondrial biogenesis and substrate utilization, markers of inflammation, oxidative stress and early vascular damage, peak oxygen uptake (VO2peak) during a maximal exercise test, other exercise tests, tissue oxygen extraction during exercise (Near-infrared spectroscopy, NIRS), energy expenditure and physical activity in daily life (metabolic Holter and questionnaire). Monitoring of blood glucose will also be carried out over a 48h period, comprising an exercise session (Continuous Glucose Monitoring System). Metabolic features, exercise tests, body composition, daily physical activity and expression of relevant genes in the muscle will also be assessed 1 yr after completion of the training programs, to establish whether some changes may persist over time.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Type 2 Diabetes
    Keywords
    aerobic training, resistance training, type 2 diabetes, therapy

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    40 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Aerobic Exercise
    Arm Type
    Experimental
    Arm Description
    The aerobic training group will use cardiovascular training devices.
    Arm Title
    Resistance Exercise
    Arm Type
    Experimental
    Arm Description
    The resistance training group will perform exercises on weight machines and free weights.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Aerobic Training
    Intervention Description
    The aerobic training group will exercise on cardiovascular training equipment. The workload will be gradually increased up to 60% of the reserve heart rate. Subjects will exercise 3 times per week for 60 min in the Fitness Centre of the Exercise and Sport Science School. Training will be carried out in small groups, under the supervision of personal trainers. During the study subjects will be instructed to follow an isocaloric diet.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Resistance Training
    Intervention Description
    The resistance training group will perform different exercises on weight machines and free weights to exercise upper and lower extremity muscles. Participants will perform 8-10 different exercises each session, alternating abdominal, upper and lower extremity exercises. Subjects will exercise 3 times per week for 60 min in the Fitness Centre of the Exercise and Sport Science School. Training will be carried out in small groups, under the supervision of personal trainers. During the study subjects will be instructed to follow an isocaloric diet.
    Primary Outcome Measure Information:
    Title
    Change in haemoglobin A1c (HbA1c) levels
    Description
    The measurement of HbA1c is carried out with a DCCT (Diabetes Control and Complications Trial)-aligned method.
    Time Frame
    4 months
    Secondary Outcome Measure Information:
    Title
    Change in body weight
    Time Frame
    4 months
    Title
    Change in body composition
    Description
    Assessment by DEXA (Dual energy X-ray absorptiometry)
    Time Frame
    4 months
    Title
    Change in fasting plasma glucose levels
    Time Frame
    4 months
    Title
    Change in total cholesterol levels
    Time Frame
    4 months
    Title
    Change in HDL-cholesterol levels
    Time Frame
    4 months
    Title
    Change in LDL-cholesterol levels
    Time Frame
    4 months
    Title
    Change in triglycerides levels
    Time Frame
    4 months
    Title
    Change in blood pressure
    Time Frame
    4 months
    Title
    Change in insulin sensitivity
    Description
    Measured by euglycemic hyperinsulinemic clamp
    Time Frame
    4 months
    Title
    Change in energy expenditure
    Description
    Measured by indirect calorimetry
    Time Frame
    4 months
    Title
    Change in antidiabetic medications
    Description
    Class and dosage of blood-glucose lowering drugs are recorded before and at the end of the protocol.
    Time Frame
    4 months
    Title
    Compliance
    Description
    Attendance at the scheduled sessions is recorded for each patient.
    Time Frame
    4 months
    Title
    Change in beta-cell function
    Description
    Measured by OGTT (Oral Glucose Tolerance Test)
    Time Frame
    4 months
    Title
    Change in energy expenditure through voluntary physical activity
    Description
    Energy expenditure is estimated through metabolic Holter (Sense Wear Armband) and IPAQ (International physical activity questionnaire).
    Time Frame
    4 months
    Title
    Change in peak oxygen uptake
    Description
    Measured during an incremental exercise test
    Time Frame
    4 months
    Title
    Change in tissue oxygen extraction
    Description
    Measured by NIRS (Near-infrared spectroscopy) during an incremental test exercise
    Time Frame
    4 months
    Title
    Change in liver and muscle fat content
    Description
    Measured by Magnetic Resonance Imaging
    Time Frame
    4 months
    Title
    Change in blood glucose during and after exercise
    Description
    Measured by continuous glucose monitoring system
    Time Frame
    48 hours
    Title
    Muscle strength
    Description
    Measured by 1RM (one-repetition maximum) test
    Time Frame
    4 months
    Title
    Change in 6 minutes walk distance
    Description
    This test measures the number of meters that can be walked in 6 minutes over a 30 m course. It is a simple field test to assess aerobic functional capacity.
    Time Frame
    4 months
    Title
    Change in flexibility
    Description
    Measured by "sit and reach" test and "back scratch" test
    Time Frame
    4 months
    Title
    Changes in expression in the muscle of some genes involved in ATP production, mitochondrial biogenesis and substrate utilization
    Description
    mRNA analysis with multiplex tandem real-time PCR of fine needle aspirates obtained from the vastus lateralis muscle
    Time Frame
    4 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    40 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: BMI between 24-36 kg/m2; HbA1c between 6.5-9.0%; diabetes diagnosis must have been made at least 1 yr previously; admitted diabetes treatments will be diet and oral hypoglycemic agents; baseline physical activity, estimated by the IPAQ questionnaire, lower than 1000 MET min per week; baseline body weight stable (changes lower than 2 kg in the last 2 months). Exclusion Criteria: moderate-severe somatic or autonomic neuropathy; coronary heart disease; peripheral or cerebral vascular disease; preproliferative or proliferative retinopathy or chronic renal failure (serum creatinine >1.4 mg/dl in females; >1.5 mg/dl in males); therapy with beta-blocker drugs; smokers; acute clinically significant intercurrent diseases; inability to perform the scheduled physical activity programs.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Paolo Moghetti, MD.,Ph.D.
    Organizational Affiliation
    Universita di Verona
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    32080720
    Citation
    Dauriz M, Olioso D, Moghetti P. Response to Comment on Olioso D, et al. "Effect of Aerobic and Resistance Training on Circulating Micro-RNA Expression Profile in Subjects with Type 2 Diabetes". J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgaa068. doi: 10.1210/clinem/dgaa068. No abstract available.
    Results Reference
    derived
    PubMed Identifier
    30445461
    Citation
    Olioso D, Dauriz M, Bacchi E, Negri C, Santi L, Bonora E, Moghetti P. Effects of Aerobic and Resistance Training on Circulating Micro-RNA Expression Profile in Subjects With Type 2 Diabetes. J Clin Endocrinol Metab. 2019 Apr 1;104(4):1119-1130. doi: 10.1210/jc.2018-01820.
    Results Reference
    derived
    PubMed Identifier
    29402509
    Citation
    Bellavere F, Cacciatori V, Bacchi E, Gemma ML, Raimondo D, Negri C, Thomaseth K, Muggeo M, Bonora E, Moghetti P. Effects of aerobic or resistance exercise training on cardiovascular autonomic function of subjects with type 2 diabetes: A pilot study. Nutr Metab Cardiovasc Dis. 2018 Mar;28(3):226-233. doi: 10.1016/j.numecd.2017.12.008. Epub 2018 Jan 2.
    Results Reference
    derived
    PubMed Identifier
    23227155
    Citation
    Bacchi E, Negri C, Trombetta M, Zanolin ME, Lanza M, Bonora E, Moghetti P. Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 Randomized Trial. PLoS One. 2012;7(12):e49937. doi: 10.1371/journal.pone.0049937. Epub 2012 Dec 5.
    Results Reference
    derived
    PubMed Identifier
    22344613
    Citation
    Bacchi E, Negri C, Zanolin ME, Milanese C, Faccioli N, Trombetta M, Zoppini G, Cevese A, Bonadonna RC, Schena F, Bonora E, Lanza M, Moghetti P. Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). Diabetes Care. 2012 Apr;35(4):676-82. doi: 10.2337/dc11-1655. Epub 2012 Feb 16.
    Results Reference
    derived

    Learn more about this trial

    Effects of Different Types of Exercise in Type 2 Diabetes

    We'll reach out to this number within 24 hrs